2018 Annual Meeting | C171 - Actualización Sobre Opciones Terapéuticas para la Epilepsia Farmacorresistente
03:30 PM - 03:35 PM | Luncheon |
Introduction
Andres M. Kanner, MD, FAAN |
03:35 PM - 04:10 PM | Speaker |
Update in Pharmacologic Treatments of Epilepsy
Vicente J. Iragui-Madoz, MD, PhD |
04:10 PM - 04:50 PM | Speaker |
Update on Non-Pharmacologic Therapies in Epilepsy
Andres M. Kanner, MD, FAAN |
04:50 PM - 05:25 PM | Speaker |
Challenging Cases of Treatment-Resistant Epilepsy: An Open Discussion
Jose E. Cavazos, MD, PhD |
05:25 PM - 05:30 PM | Closing Remarks |
Closing Remarks
Andres M. Kanner, MD, FAAN |
Andres M. Kanner, MD, FAAN | Dr. Kanner has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Eisai. Dr. Kanner has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Xenon. Dr. Kanner has received personal compensation in the range of $5,000-$9,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Epilepsy Foundation of America. Dr. Kanner has received personal compensation in the range of $500-$4,999 for serving as a Lecture at International meeting with Eisai. |
Jose E. Cavazos, MD, PhD | Dr. Cavazos has received stock or an ownership interest from Brain Sentinel . The institution of Dr. Cavazos has received research support from NIH. |
Vicente J. Iragui-Madoz, MD, PhD | No disclosure on file |